Neuron23 Funding & Investors
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
neuron23.comTotal Amount Raised: $213,500,000
Neuron23 Funding Rounds
Series C
$100,000,000
Series C Investors
Redmile GroupSoftBank Investment AdvisersWestlake Village BioPartnersAcorn BioventuresHBM PartnersPerceptive AdvisorsKleiner Perkins Caufield & ByersCowenSurveyor CapitalSeries B
$80,000,000
Series B Investors
HBM Healthcare InvestmentsRedmile GroupWestlake Village BioPartnersAcorn BioventuresHBM PartnersPerceptive AdvisorsKleiner Perkins Caufield & ByersSurveyor CapitalCowenSeries A
$33,500,000
Series A Investors
Westlake Village BioPartnersKleiner Perkins Caufield & Byers
Funding info provided by Diffbot.